<bill session="113" type="s" number="914" updated="2016-10-25T16:24:13Z">
  <state datetime="2013-05-09">REFERRED</state>
  <status>
    <introduced datetime="2013-05-09"/>
  </status>
  <introduced datetime="2013-05-09"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to permit direct payment to pharmacies for certain compounded drugs that are prepared by the pharmacies for a specific beneficiary for use through an implanted infusion pump.</title>
    <title type="display">A bill to amend title XVIII of the Social Security Act to permit direct payment to pharmacies for certain compounded drugs that are prepared by the pharmacies for a specific beneficiary for use through an implanted infusion pump.</title>
  </titles>
  <sponsor bioguide_id="C000567"/>
  <cosponsors>
    <cosponsor bioguide_id="W000437" joined="2013-05-09"/>
  </cosponsors>
  <actions>
    <action datetime="2013-05-09">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2013-05-09">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S3330"/>
    </action>
    <action datetime="2013-05-09" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="113" relation="unknown" number="232"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug therapy"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2013-05-09T04:00:00Z" status="Introduced in Senate">Amends title XVIII (Medicare) of the Social Security Act to authorize direct payment under part B (Supplementary Medical Insurance Benefits for the Aged and Disabled) to a pharmacy for certain covered compound drugs prepared by the pharmacy for a specific beneficiary for the effective use of an implanted infusion pump.</summary>
  <committee-reports/>
</bill>
